Cargando…

CHEK2 Pathogenic Germline Variants in Patients With NSCLC

Detalles Bibliográficos
Autor principal:	Sorscher, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719079/ https://www.ncbi.nlm.nih.gov/pubmed/36471681 http://dx.doi.org/10.1016/j.jtocrr.2022.100439

Ejemplares similares

RNA Sequencing Provides Evidence for Pathogenicity of a Novel CHEK2 Splice Variant (C.1009-7T>G)
por: Na, Rae, et al.
Publicado: (2022)

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
por: Stolarova, Lenka, et al.
Publicado: (2020)

Prevalence of the CHEK2 R95* germline mutation
por: Knappskog, Stian, et al.
Publicado: (2016)

Association of Germline CHEK2 Gene Variants with Risk and Prognosis of Non-Hodgkin Lymphoma
por: Havranek, Ondrej, et al.
Publicado: (2015)

Concurrent germline BRCA1, BRCA2, and CHEK2 pathogenic variants in hereditary breast cancer: a case series
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Rate of Pathogenic Germline Variants in Patients With Lung Cancer
por: Sorscher, Steven, et al.
Publicado: (2023)

Case report: Two sisters with a germline CHEK2 variant and distinct endocrine neoplasias
por: Vallera, Raphaelle D., et al.
Publicado: (2022)

Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors
por: Kirchner, Kira, et al.
Publicado: (2023)

Detecting spread of SARS‐CoV‐2 variants using PowerChek SARS‐CoV‐2 S‐gene mutation detection kit
por: Kim, Hyun Jin, et al.
Publicado: (2022)

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk
por: Stolarova, Lenka, et al.
Publicado: (2023)

Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
por: Velthuizen, Mary E., et al.
Publicado: (2021)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Burkitt Lymphoma as Fourth Neoplasia in a Patient Affected by Cowden Syndrome with a Novel PTEN Germline Pathogenic Variant
por: Galli, Eugenio, et al.
Publicado: (2020)

Germline mutation of CHEK2 in neurofibromatosis 1 and 2: Two case reports
por: Li, Qiang, et al.
Publicado: (2018)

High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
por: Rainville, Irene, et al.
Publicado: (2020)

Why the length of recurrence-free survival or ‘lead-times’ can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
por: Sorscher, Steven
Publicado: (2023)

The repertoire of germline variants in patients with early‐onset rectal cancer
por: Beltrami, Caroline Moraes, et al.
Publicado: (2022)

The First Case Report of a Patient With Oligodendroglioma Harboring CHEK2 Germline Mutation
por: Li, Xueen, et al.
Publicado: (2022)

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers
por: Toss, Angela, et al.
Publicado: (2021)

A High Percentage of NSCLC With Germline CHEK2 Mutation Harbors Actionable Driver Alterations: Survey of a Cancer Genomic Database and Review of Literature
por: Zhang, Shannon S., et al.
Publicado: (2022)

Clinical Trials in Oncology and Defining Benefit
por: Sorscher, Steven
Publicado: (2017)

Circulating cell-free DNA use for diagnosing cholangiocarcinoma
por: Sorscher, Steven
Publicado: (2019)

Incidence Evaluation of SARS-CoV-2 Variants in the Ulsan Area, Korea, Using PowerChek SARS-CoV-2 S-gene Mutation Detection Kit: A Pilot Study
por: Park, Sang Hyuk, et al.
Publicado: (2022)

Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
por: Gao, Yinjie, et al.
Publicado: (2021)

Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care—Checking CHEK2
por: Bychkovsky, Brittany L., et al.
Publicado: (2022)

CHEK2 variants associate with hereditary prostate cancer
por: Seppälä, E H, et al.
Publicado: (2003)

A Case Report of CHEK2 and MUTYH Germline Mutations Associated With Cholangiocarcinoma in a Young Patient
por: Rehman, Obaid, et al.
Publicado: (2022)

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
por: Petridis, Christos, et al.
Publicado: (2019)

Common clonal origin of chronic myelomonocytic leukemia and B-cell acute lymphoblastic leukemia in a patient with a germline CHEK2 variant
por: Bazinet, Alexandre, et al.
Publicado: (2021)

The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers
por: Mandelker, Diana, et al.
Publicado: (2019)

Multiple Primary Melanoma in a CHEK2 Mutation Carrier
por: Álvarez-Salafranca, Marcial, et al.
Publicado: (2023)

The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms
por: Oddsson, A, et al.
Publicado: (2014)

Copy number variants and rasopathies: germline KRAS duplication in a patient with syndrome including pigmentation abnormalities
por: Gilbert-Dussardier, Brigitte, et al.
Publicado: (2016)

Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia
por: Cardoso, S R, et al.
Publicado: (2016)

Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population
por: Wang, Shijia, et al.
Publicado: (2018)

An American patient with polyposis carrying a Scandinavian AXIN2 pathogenic variant
por: Macklin-Mantia, Sarah K., et al.
Publicado: (2020)

Germline pathogenic variants in 786 neuroblastoma patients
por: Kim, Jung, et al.
Publicado: (2023)

Inappropriate interpretation of non‐pathogenic HTRA1 variant as pathogenic
por: Uemura, Masahiro, et al.
Publicado: (2023)

Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC
por: Xu, Zheyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8738orrtsmfqrms5araj0etudr